Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Dow
Federal Trade Commission
Colorcon
McKesson
Citi
Johnson and Johnson
Cipla

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050582

« Back to Dashboard

NDA 050582 describes DORYX, which is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma, and is included in three NDAs. It is available from two suppliers. There are five patents protecting this drug and seven Paragraph IV challenges. Additional details are available on the DORYX profile page.

The generic ingredient in DORYX is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-eight suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 050582
Tradename:DORYX
Applicant:Mayne Pharma Intl
Ingredient:doxycycline hyclate
Patents:0
Therapeutic Class:Antibacterials
Dental and Oral Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Jul 22, 1985TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrengthEQ 75MG BASE
Approval Date:Aug 13, 2001TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
UBS
Cipla
Fuji
Merck
Cantor Fitzgerald
Healthtrust
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.